Macrophages are a heterogeneous population of immune cells playing several and diverse functions in homeostatic and immune responses. The broad spectrum of macrophage …
A Calcinotto, J Kohli, E Zagato… - Physiological …, 2019 - journals.physiology.org
Cellular senescence is a permanent state of cell cycle arrest that occurs in proliferating cells subjected to different stresses. Senescence is, therefore, a cellular defense mechanism that …
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have shown unprecedented clinical activity in several types of cancer and are rapidly transforming the …
The contribution of nerves to the pathogenesis of malignancies has emerged as an important component of the tumour microenvironment. Recent studies have shown that …
AA Martí i Líndez, W Reith - Cellular and Molecular Life Sciences, 2021 - Springer
A growing body of evidence indicates that, over the course of evolution of the immune system, arginine has been selected as a node for the regulation of immune responses. An …
Y Wang, KCC Johnson, ME Gatti-Mays, Z Li - Journal of hematology & …, 2022 - Springer
Immune checkpoint inhibitors targeting programmed cell death protein 1, programmed death- ligand 1, and cytotoxic T-lymphocyte-associated protein 4 provide deep and durable …
S Hendry, R Salgado, T Gevaert… - Advances in anatomic …, 2017 - journals.lww.com
Assessment of the immune response to tumors is growing in importance as the prognostic implications of this response are increasingly recognized, and as immunotherapies are …
TM Beer, ED Kwon, CG Drake, K Fizazi… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Ipilimumab increases antitumor T-cell responses by binding to cytotoxic T- lymphocyte antigen 4. We evaluated treatment with ipilimumab in asymptomatic or minimally …
J Stultz, L Fong - Prostate cancer and prostatic diseases, 2021 - nature.com
Background Advanced prostate cancer remains one of the most common and deadly cancers, despite advances in treatment options. Immunotherapy has provided little benefit to …